Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Phase III Data Showed Novartis Investigational Bronchodilator QAB149 Significantly Improved Lung Function In COPD Patients
The Novartis investigational bronchodilator QAB149 (indacaterol) met the primary efficacy endpoints of improved lung function compared to placebo at 12 weeks in three pivotal phase III studies in chronic obstructive pulmonary disease (COPD) patients. In secondary endpoints of these studies, QAB149 demonstrated clinically relevant lung function improvements within five minutes of the first dose, lasting for 24 hours in COPD patients.

In Patients With Diabetes And Stable Heart Disease, Medical Therapy Equal To Bypass, Angioplasty
Optimal medical therapy for patients with diabetes and stable coronary heart disease is equally effective at lowering the risk of death, heart attack, and stroke as prompt revascularization procedures with either coronary bypass surgery or angioplasty, according to results from an international multicenter clinical trial supported by the National Institutes of Health. Optimal medical therapy includes intensive drug therapy and lifestyle interventions, such as dietary changes and smoking cessation.
News of the day
Delays To Seeing Docs Stretch On
A new study finds the average wait for a medical appointment has increased by more than a week since 2004, to 8.6 days, USA Today reports. In Boston, the worst-performing city of the 15 surveyed for the Merritt Hawkins and Associates study, patients waited nearly 50 days, on average, to see a doctor.
Oncology

Eighth International Conference On Bipolar Disorder To Be Held In Pittsburgh, June 25 To 27

Nearly 1,000 researchers, clinicians and mental health advocates are expected to attend the Eighth International Conference on Bipolar Disorder, June 25 to 27, at the David L. Lawrence Convention Center in Pittsburgh. The event is held only once every two years and is the largest meeting of its kind solely devoted to bipolar disorder, a disease that affects almost six million Americans. Top medical institutions from around the world will present new research covering the classification of bipolar disorders, revolutionary technologies such as genomics and brain imaging, optimizing current treatments of bipolar depression, advances in neurobiology and genetics, psychoeducation and psychotherapy, medical risk prevention and intervention, and international perspectives on bipolar disorder. The first two days of the program will consist of scientific sessions on topics including: clinical trial data, genetics, neuroscience, imaging, psychosocial treatments, childhood bipolar disorder, diagnostic issues, substance abuse, medical comorbidities and suicide. Saturday"s program will focus on diagnostic criteria and planning for the new Diagnostic and Statistical Manual of Mental Disorders (DSM-V), clinical trials and international perspectives on bipolar disorder. Other events include advanced psychotherapy workshops on cognitive behavioral therapy, family focused therapy, and interpersonal and social rhythm therapy. Advocacy-related forums will take place throughout the conference. Each day will include sessions for both clinicians and for individuals who have bipolar disorder and their families. A staffed press room will be available on site, and media briefings will be held Thursday, June 25, and Friday, June 26. To register as press, please contact Megan Grote Quatrini at GroteME@upmc.edu or call UPMC Media Relations at (412) 647-3555. Press room guidelines, preliminary scientific program and hotel information are available at http://www.8thbipolar.org. The Eighth International Conference on Bipolar Disorder is being sponsored by the University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic of UPMC. University of Pittsburgh School of Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009